投资者关系

所有财务和投资者信息都可以在 c-rad.com 上以英文获取。请点击此处查看信息。

如果您有任何问题，请随时通过investors@c-rad.com与我们联系。

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash

Press releases

View all
2021-12-17 09:30 C-RAD achieves another milestone ensuring the availability of SGRT, the standard of care for radiotherapy News Corporate Information Other Corporate Information English IR
2021-10-28 10:30 Revenue growth with increased profitability News English Regulatory MAR Report Interim Q3 IR
2021-10-28 08:30 Tillväxt med förbättrad lönsamhet News Swedish Regulatory MAR Report Interim Q3 IR
2021-10-25 08:30 Reminder: C-RAD Web Presentation Interim Report Q3 2021 News Corporate Information Other Corporate Information English IR
2021-10-14 08:30 C-RAD Web Presentation Interim Report Q3 2021 News Corporate Information Other Corporate Information English IR
2021-10-04 13:00 C-RAD and Accuray sign agreement to enhance Radixact® system breast cancer treatment capabilities News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
PreviousNext

Shares & stock

View shareholders

Please feel free to contact us regarding investements or other financial questions

If you have any questions, please don’t hesitate to contact us

+46 18 666930    investors@c-rad.com